| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BTOGBIT ORIGIN Ltd | 10.19M | 0.12 | -0.03 | -53.87% | -6.68% | -313.89% | 5.68 | |
| ABVEAbove Food Ingredients Inc. Common Stock | 102.38M | 2.00 | -0.32 | -7.07% | -24.6% | -80.94% | 3.42% | |
| COOTAustralian Oilseeds Holdings Limited Ordinary Shares | 22.6M | 0.81 | -1.11 | 16.27% | -66.01% | -481.29% | 19.90 | |
| FAMIFarmmi, Inc. | 7.24M | 1.32 | -2 | -41.89% | -2.87% | -2.25% | 0.09 | |
| NCRANocera, Inc. | 12.69M | 0.88 | -4.91 | -28.86% | -24.59% | -71.02% | 0.01 |
| Dec 2020 | Jan 2022 | Jan 2023 | Jan 2024 | |
|---|---|---|---|---|
| Sales/Revenue | 0 | 198.86M | 396.46M | 368.42M |
| Revenue Growth % | - | - | 0.99% | -0.07% |
| Cost of Goods Sold | 0 | 190.95M | 397.74M | 374.32M |
| COGS % of Revenue | - | 0.96% | 1% | 1.02% |
| Gross Profit | 0 | 7.91M | -1.28M | -5.9M |
| Gross Margin % | - | 0.04% | -0% | -0.02% |
| Gross Profit Growth % | - | - | -1.16% | -3.61% |
| Operating Expenses | 1.02K | 11.93M | 38.4M | 36.2M |
| OpEx % of Revenue | - | 0.06% | 0.1% | 0.1% |
| Selling, General & Admin | 1.02K | 10.83M | 27.64M | 30.35M |
| SG&A % of Revenue | - | 0.05% | 0.07% | 0.08% |
| Research & Development | 0 | 235.09K | 430.67K | 171.85K |
| R&D % of Revenue | - | 0% | 0% | 0% |
| Other Operating Expenses | 0 | 862.42K | 10.33M | 5.68M |
| Operating Income | -1.02K | -4.02M | -39.68M | -42.1M |
| Operating Margin % | - | -0.02% | -0.1% | -0.11% |
| Operating Income Growth % | - | -3930.55% | -8.88% | -0.06% |
| EBITDA | -1.02K | -2.65M | -36.72M | -38.49M |
| EBITDA Margin % | - | -0.01% | -0.09% | -0.1% |
| EBITDA Growth % | - | -2593.23% | -12.86% | -0.05% |
| D&A (Non-Cash Add-back) | 0 | 1.37M | 2.96M | 3.61M |
| EBIT | 0 | -3.79M | -39.39M | -41.85M |
| Net Interest Income | 0 | -2.15M | -5.3M | -7.81M |
| Interest Income | 0 | 82.29K | 296.48K | 245.26K |
| Interest Expense | 0 | 2.09M | 5.38M | 7.67M |
| Other Income/Expense | 0 | -1.86M | -5.32M | -7.42M |
| Pretax Income | -1.02K | -5.87M | -45.01M | -49.52M |
| Pretax Margin % | - | -0.03% | -0.11% | -0.13% |
| Income Tax | 0 | -95.09K | 477.78K | 3.79M |
| Effective Tax Rate % | 1% | 0.98% | 1.01% | 1.08% |
| Net Income | -1.02K | -5.78M | -45.48M | -53.31M |
| Net Margin % | - | -0.03% | -0.11% | -0.14% |
| Net Income Growth % | - | -5640.83% | -6.87% | -0.17% |
| Net Income (Continuing) | -802 | -5.78M | -45.48M | -53.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -0.22 | -1.76 | -6.21 |
| EPS Growth % | - | - | -7% | -2.53% |
| EPS (Basic) | 0.00 | -0.22 | -1.76 | -6.21 |
| Diluted Shares Outstanding | 22.46M | 25.61M | 24.89M | 8.59M |
| Basic Shares Outstanding | 22.46M | 25.61M | 24.89M | 8.59M |
| Dividend Payout Ratio | - | - | - | - |
| Dec 2020 | Jan 2022 | Jan 2023 | Jan 2024 | |
|---|---|---|---|---|
| Total Current Assets | 42.08K | 499.71K | 125.42K | 68.44M |
| Cash & Short-Term Investments | 42.08K | 89.39K | 2.33M | 947 |
| Cash Only | 42.08K | 89.39K | 2.33M | 952.28K |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 27.18M | 35.71M | 24.7M |
| Days Sales Outstanding | - | 49.89 | 32.87 | 24.47 |
| Inventory | 0 | 50.39M | 47.92M | 26.01M |
| Days Inventory Outstanding | - | 96.33 | 43.97 | 25.36 |
| Other Current Assets | 0 | -77.69M | -87.8M | 16.5M |
| Total Non-Current Assets | 225.63K | 200.01M | 30.29M | 75.45M |
| Property, Plant & Equipment | 0 | 55.95M | 64.56M | 65.55M |
| Fixed Asset Turnover | - | 3.55x | 6.14x | 5.62x |
| Goodwill | 0 | 2.54M | 0 | 871.17K |
| Intangible Assets | 0 | 562.07K | 2.94M | 2.45M |
| Long-Term Investments | 0 | 200.01M | 30.29M | 5.87M |
| Other Non-Current Assets | 225.63K | -59.05M | -67.49M | 711K |
| Total Assets | 267.71K | 200.51M | 30.42M | 143.89M |
| Asset Turnover | - | 0.99x | 13.03x | 2.56x |
| Asset Growth % | - | 747.99% | -0.85% | 3.73% |
| Total Current Liabilities | 236.81K | 100.39M | 1.25M | 153.85M |
| Accounts Payable | 0 | 34.84M | 47.4M | 53.1M |
| Days Payables Outstanding | - | 66.6 | 43.49 | 51.78 |
| Short-Term Debt | 83K | 47.05M | 76.5M | 79.09M |
| Deferred Revenue (Current) | 0 | 588.74K | 1000K | 1000K |
| Other Current Liabilities | 153.81K | 8.85M | -135.81M | 4.6M |
| Current Ratio | 0.18x | 0.00x | 0.10x | 0.44x |
| Quick Ratio | 0.18x | -0.50x | -38.37x | 0.28x |
| Cash Conversion Cycle | - | 79.62 | 33.35 | -1.95 |
| Total Non-Current Liabilities | 0 | 185.76K | 37.1M | 36.3M |
| Long-Term Debt | 0 | 1.03M | 577.52K | 186.1K |
| Capital Lease Obligations | 0 | 34.88M | 36.53M | 35.86M |
| Deferred Tax Liabilities | 0 | 78.68K | 0 | 247.07K |
| Other Non-Current Liabilities | 0 | 185.76K | 0 | 0 |
| Total Liabilities | 236.81K | 652.18K | 1.31M | 190.15M |
| Total Debt | 83K | 84.65M | 115.61M | 117.51M |
| Net Debt | 40.92K | 84.56M | 113.28M | 116.55M |
| Debt / Equity | 2.69x | 0.42x | 3.97x | - |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - |
| Interest Coverage | - | -1.93x | -7.38x | -5.49x |
| Total Equity | 30.9K | 199.86M | 29.11M | -46.26M |
| Equity Growth % | - | 6467.55% | -0.85% | -2.59% |
| Book Value per Share | 0.00 | 7.80 | 1.17 | -5.38 |
| Total Shareholders' Equity | 30.9K | 32.18M | 29.11M | -46.26M |
| Common Stock | 642 | 722 | 775 | 781 |
| Retained Earnings | -1.02K | -5.08M | -50.57M | -103.88M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 47.94K | 167.72K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Dec 2020 | Jan 2022 | Jan 2023 | Jan 2024 | |
|---|---|---|---|---|
| Cash from Operations | -435 | -944.05K | -978.98K | 7.15M |
| Operating CF Margin % | - | -0% | -0% | 0.02% |
| Operating CF Growth % | - | -2169.23% | -0.04% | 8.3% |
| Net Income | -1.02K | -5.78M | -45.48M | -53.31M |
| Depreciation & Amortization | 0 | 1.37M | 2.96M | 3.61M |
| Stock-Based Compensation | 0 | 0 | 6.91M | 3.09M |
| Deferred Taxes | 0 | -95.09K | -78.68K | 0 |
| Other Non-Cash Items | 0 | 27.54M | 25.64M | 9.51M |
| Working Capital Changes | 589 | -23.97M | 9.08M | 44.25M |
| Change in Receivables | 0 | -9.71M | -8.65M | 9.81M |
| Change in Inventory | 0 | -25.99M | 5.55M | 21.91M |
| Change in Payables | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | -200M | 172.15M | -4.52M |
| Capital Expenditures | 0 | -22.13M | -2.39M | -3.65M |
| CapEx % of Revenue | - | 0.11% | 0.01% | 0.01% |
| Acquisitions | - | - | - | - |
| Investments | - | - | - | - |
| Other Investing | 0 | -173.84M | 181.07M | 723.8K |
| Cash from Financing | 42.52K | 201M | -171.17M | -4.01M |
| Debt Issued (Net) | - | - | - | - |
| Equity Issued (Net) | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - |
| Other Financing | 42.52K | 172.24M | -194.87M | -2.16M |
| Net Change in Cash | - | - | - | - |
| Free Cash Flow | -435 | -23.08M | -3.7M | 3.5M |
| FCF Margin % | - | -0.12% | -0.01% | 0.01% |
| FCF Growth % | - | -53052.7% | 0.84% | 1.95% |
| FCF per Share | -0.00 | -0.90 | -0.15 | 0.41 |
| FCF Conversion (FCF/Net Income) | 0.42x | 0.16x | 0.02x | -0.13x |
| Interest Paid | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 |
| Metric | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Return on Equity (ROE) | -3.31% | -5.78% | -39.73% | - |
| Return on Invested Capital (ROIC) | - | -2.12% | -13.95% | -29.69% |
| Gross Margin | - | 3.98% | -0.32% | -1.6% |
| Net Margin | - | -2.91% | -11.47% | -14.47% |
| Debt / Equity | 2.69x | 0.42x | 3.97x | - |
| Interest Coverage | - | -1.93x | -7.38x | -5.49x |
| FCF Conversion | 0.42x | 0.16x | 0.02x | -0.13x |
| Revenue Growth | - | - | 99.37% | -7.07% |
Above Food Ingredients Inc. Common Stock (ABVE) reported $94.7M in revenue for fiscal year 2023.
Above Food Ingredients Inc. Common Stock (ABVE) saw revenue decline by 7.1% over the past year.
Above Food Ingredients Inc. Common Stock (ABVE) reported a net loss of $23.3M for fiscal year 2023.
Above Food Ingredients Inc. Common Stock (ABVE) had negative free cash flow of $2.5M in fiscal year 2023, likely due to heavy capital investments.